Neuregulins as potential drugs for neurological disorders.
Marchionni
M A
MA
Cambridge NeuroScience, Inc., Massachusetts 01239, USA.
Kirk
C J
CJ
Isaacs
I J
IJ
Hoban
C J
CJ
Mahanthappa
N K
NK
Anton
E S
ES
Chen
C
C
Wason
F
F
Lawson
D
D
Hamers
F P
FP
Canoll
P D
PD
Reynolds
R
R
Cannella
B
B
Meun
D
D
Holt
W F
WF
Matthew
W D
WD
Chen
L E
LE
Gispen
W H
WH
Raine
C S
CS
Salzer
J L
JL
Gwynne
D I
DI
D000818:Animals; D006023:Glycoproteins / Q000502:physiology*; D006801:Humans; D009414:Nerve Growth Factors / Q000502:physiology*; D009420:Nervous System / Q000254:growth & development; D009422:Nervous System Diseases / Q000188:drug therapy*; D009424:Nervous System Physiological Phenomena; D020880:Neuregulins; D011994:Recombinant Proteins
D006023:Glycoproteins; D009414:Nerve Growth Factors; D020880:Neuregulins; D011994:Recombinant Proteins